XBI ETF: State Street SPDR S&P Biotech ETF - Price, Holdings & Analysis
State Street SPDR S&P Biotech ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About State Street SPDR S&P Biotech ETF
What is the current price of XBI?
The latest XBI price is $128.96. The 52-week range is $66.66–$132.09. XBI has returned 64.5% over the past 52 weeks.
What is the expense ratio for XBI?
XBI's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does XBI pay dividends?
Yes, XBI pays a 0.35% dividend yield. The last ex-dividend date was 2026-03-26. View full dividend history in the Dividends section.
What are the top holdings of XBI?
XBI's largest holdings are Apellis Pharmaceuticals, Inc. (1.8%), Moderna, Inc (1.8%), Halozyme Therapeutics, Inc (1.6%) (combined weight: 5.2%). The fund holds 156 total positions. View the complete portfolio breakdown in the Holdings section.
How does XBI compare to similar ETFs?
Compare XBI (0.35% expense ratio, $8.10B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.